To learn more about recent and upcoming presentations, please contact csdd@tufts.edu.

Upcoming Presentations

 

Having the End in Mind:  Building Quality into Clinical Trials
DIA Annual Meeting | San Diego, CA | June 17
 
 
An Update on the PALADIN Consortium
DIA Annual Meeting | San Diego, CA | June 18
 

Improving Communication Across Differences in Drug Development Teams

Jennifer Kim, & Emily Botto,

DIA Annual Meeting | San Diego, CA | June 19

 

Regulatory Affairs of the Future: Is Now

Maria Florez

DIA Annual Meeting | San Diego, CA | June 20

 

Panel: The Impact of Racial Discrimination on the Patient Clinical Trial Experience

Host: Jennifer Kim & Panelist: Madison Ford

DIA Annual Meeting  | San Diego, CA | June 20

 

Measuring RBQM Adoption: Insights and Opportunities

Maria Florez  & Abigail Dirks

13th Clinical Trials in Oncology East Coast | Boston, MA | July 9 

 

Panel: Measuring the ROI of DCT Solutions

Zak Smith

Mobile in Clinical Trials | Philadelphia, PA | September 16

 

Uptake of AI in Clinical Research: Trial Planning and Execution

Mary Jo Lamberti 

DPHARM

Philadelphia, PA | September 17-18th

 

Keynote on the Evolving Global Site Landscape

Site Solutions Summit | Hollywood, FL | Sept 29

 

PACT Consortium Results

Zak Smith

IRT Boston | Boston, MA | October 16

 

Tufts CSDD – DIA Study Results: Use of AI in Clinical Development

Mary Jo Lamberti  & Maria Florez

Boston, MA | October 23

 

Amplifying and Assessing Patient & Site Participation Burden Based on Protocol Design Elements and Identifying Opportunities to Lower Burden and Optimize Clinical Execution

Zak Smith

SCOPE Europe 2024

Barcelona | October 23- 24

 

Identifying Efficiencies and Improvement Opportunities in the Vendor Qualification Process

Zak Smith

SCOPE Europe 2024

Barcelona | October 23- 24

 

Report Card on the Patient Engagement Movement

Ken Getz

Outsourcing Clinical Trials | Boston, MA | Oct 24

 


Recent Presentations

May 2024

Assessing the Financial Value of Patient Engagement: A Quantitative Approach From CTTI’s Patient Groups and Clinical Trials Project

Jennifer Kim

DIA China 2024

Suzhou, China | May 18

 

DCT/Technique Empowered High-Efficiency Clinical Trial

Jennifer Kim

DIA China 2024

Suzhou, China | May 18

 

Fireside Chat

Maria Florez

8th Decentralized and Hybrid Clinical Trials, 

Philadelphia, PA | May 16

 

Retail Pharmacies and Clinical Trials: Perspectives from Industry, Sites & Patients

Emily Botto

Association of Clinical Research Professionals 2024

Anaheim, CA | May 4

 

Benchmarking Patient Enrollment and Use of Patient Recruitment Tactics in Global Trials

Mary Jo Lamberti

World BI

Boston, MA | May 2 

April 2024

 

Protocol Simplification or Optimization?

Ken Getz

CMO Summit

Boston, MA | April 17

 

Quantifying the Financial Value of Digital Endpoints in Clinical Trials | Data Driven, Hybrid & Full Decentralized Trials

Joseph DiMasi

Informa Connect

Philadelphia, PA | April 16-17

 

Panel Discussion on Innovation Adoption

Ken Getz

InformaConnect

Philadelphia, PA | April 16

 

Frequency and Impact of Protocol Amendments on Clinical Trial Performance

Emily Botto

Festival of Biologics

San Diego, CA | April 15

 

Where has the Industry Been and Where Should it be Going?: Using Industry Development Benchmarks (Time, Risk, and Cost Metrics) to Improve Performance

Joseph DiMasi

Drug Development Boot Camp, Speid & Associates, Inc & Brown University Alpert Medical School

Virtual | April 11 

 

Anticipating New Directions in Response to a Changing Drug Development Landscape

Ken Getz

EQuaTR – NorthWestern University Feinberg School of Medicine

Chicago IL | April 10

 

DEI from Within: The Impact of Diverse Clinical Research Teams on Patient Inclusion

Jennifer Kim

SCRS Site Solutions Summit

Atlanta, GA | April 8

 

DEI from Within: Keynote

Jennifer Kim

SCRS Site Solutions Summit

Atlanta, GA | April 8

 

Navigating Academia. Colloquium.

Jennifer Kim

Teachers College, Columbia University New York, NY | April 9

 

March 2024

 

Amplifying and Applying Patient Voices in Protocol Planning and Design

Ken Getz

Patients as Partners

Philadelphia, PA | March 22

 

Workshop: Upskilling for Successful Digital Transformations in Europe

Maria Florez

DIA Europe

Brussels, BE | March 12-13

 

Optimization in the Age of Hyper-Customization

Ken Getz

Harvard – MIT Center for Regulatory Science

Virtual | March 5

February 2024

Site Activation and Patients Enrollment Benchmarks Among Sponsors and CROs

Mary Jo Lamberti

Summit for Clinical Operations Executives (SCOPE)

Orlando, FL| February 14

 

Assessing Current Levels and Identifying Barriers to RBQM Adoption

Ken Getz

Summit for Clinical Operations Executives (SCOPE)

Orlando, FL | February 14

 

Protocol Design Trends and Their Impact on Performance

Ken Getz

Summit for Clinical Operations Executives (SCOPE)

Orlando, FL | February 14


January 2024

Optimizing Study Design and Setting the Stage for Efficient Study Conduct Through Quality by Design

Ken Getz

Robert J. Margolis Center for Health Policy at Duke University and the Food and Drug Administration

Washington DC | January 31

 

Measuring RBQM Adoption: Insights & Opportunities

Maria Florez & Abigail Dirks

Dynamic Global Events RBQM Summit

Philadelphia, PA | January 25

 

The Promise and Perils of Decentralized Clinical Trials (DCT)

Ken Getz

Tufts CSDD – Cambridge University Joint Webinar

Virtual | January 22

 

Advancing Diversity in Clinical Trials: Insights from Recent Research 

Ken Getz

LinkedIn Live

Virtual | January 18

December 2023

Outsourcing Customization Strategies and their Relationship with Clinical Trial Performance Optimization

Ken Getz

ICON, Partner of Choice

Virtual | December 7

 

Leveraging Patient Engagement Strategies to Optimize Protocol Performance

Ken Getz

Evolution Summit

Live | December 4

November 2023

Understanding and Overcoming Barriers to Technology Adoption in Clinical Trials

Maria Florez, MA

Clinical Trials Innovation Programme US

Brooklyn, NY | November 17

 

Diversity and Representation in Oncology Trials

Zachary Smith, MA

Cancer Immunotherapy Summit

Boston, MA | Nov 6 - 8

 

Adoption Cycle for Technologies that Support DCTs

Maria Florez

Webcast Series: Effectively Adopt a Decentralized Approach, DCT Week

Virtual | November 7

 

Measuring Patient and Site Burden in Clinical Trials

Ken Getz, MBA

DIA Annual Meeting Japan

Live | November 5 - 8

 

Assessing the Net Financial Benefits of Employing Digital Endpoint in Clinical Trials

Joseph DiMasi, PhD

4th Annual Digital Biomarkers & Digital Measurements East Summit

Boston, MA | November 2

 

Optimizing Clinical Trial Performance

Ken Getz, MBA

OCT New England

Live | November 2

 

Benchmarking Patient Enrollment and Use of Patient Recruitment Tactics

Mary Jo Lamberti, PhD

Outsourcing in Clinical Trials New England

Boston, MA | November 1

October 2023

Clinical Trial Disruptions During Disasters and Public Health Emergencies

Ken Getz

CTTI and FDA public meeting

Virtual | October 18 - 19

 

Envisioning the Future Landscape: Preparing the Future Workforce for Drug Research & Development - A Workshop

Mary Jo Lamberti

National Academies

Washington D.C. | October 16-17

 

Adopting Technologies that Enable Digital Transformations

Maria Florez

Precision in Clinical Trials Summit

San Diego, CA | October 16

 

Overcoming Barriers Slowing the Adoption of Disruptive Technologies

Maria Florez

Disruptive Technologies in Clinical Trials

Boston, MA | October 10

 

Examining the Vendor Qualification and Selection Process

Ken Getz

CORE East

Live | October 4-6

 


September 2023

Patient Preferences for Virtual and Remote Clinical Trial Services

Ken Getz, MBA

DPharm

Live | September 22

 

Increasing R&D Productivity to Sustain Biomedical Innovation

Ken Getz

IQVIA Institute Life Sciences Innovation Forum

Virtual | September 26


August 2023

How Lack of Inclusion Can Impact Women In STEM

Jennifer Kim, PhD

Cornell School of Medicine

Live | August 31st

 

Methods in Organizational Change Research: Dialogue on the Past, Present, and Future of Organization

Jennifer Kim, PhD

Academy of Management

Boston, MA | August 

 

Silence is Not Always Golden: Impact of Leader Intervention Against COVID-19 Microaggressions

Jennifer Kim, PhD

Academy of Management

Boston, MA | August 

 


July 2023

A Site Perspective: The Impact of the Last 5 Years

Abigail Dirks, MS

Clinical Operations in Oncology Trials East Coast

Boston, MA | July 11


June 2023

Performance, Interrupted: Examining DEI Dynamics That can Impact Team Performance in Drug Development

Jennifer Kim, PhD

DIA Annual Meeting

Boston, MA | June 26 - 29

 

Measuring Impact of Patient Engagement Across Research and Development

Jennifer Kim, PhD

DIA Annual Meeting

Boston, MA | June 26 - 29

 

Sponsor-CRO Collaborations and the Impact of Decentralized Clinical Trials

Mary Jo Lamberti, PhD

DIA Annual Meeting

Boston, MA | June 26

 

Maximizing Diversity in Clinical Trials

Ken Getz, MBA

Finn Partners

Boston, MA | June 20

 

The Impact of Patient Engagement on Drug Development Performance

Ken Getz, MBA

DIA China

Virtual | June 17

 

The Impact of the Last 5 Years on Investigative Sites

Abigail Dirks, MS and Ken Getz, MBA

ACRP

Virtual | June 14

 

Clinical Trials for Small Biotechs

Ken Getz, MBA

STAT News

Virtual | June 12


May 2023

Innovation in Clinical Research: Why it Takes So Long to Adopt a New Solution

Ken Getz, MBA

MAGI East Conference

Philadelphia, PA | May 21 - 24

 

Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs

Joseph DiMasi

PhRMA R&D Roundtable

Boston, MA | May 11

 

Managing Protocol Complexity to Optimize Clinical Trial Performance

Ken Getz, MBA

Linking Leaders

Boston, MA | May 10


April 2023

The Economics of Implementing Phase 0 Techniques - Methods for Measuring Financial Value

Joseph DiMasi, PhD

4th International Phase-0/Microdosing Stakeholder Meeting: Intra-Target Microdosing (ITM): Revolutionizing Clinical Pharmacology and Drug Development

Boston, MA | April 24

 

The Impact of DCT Use of Sponsor-CRO Relationships

 Mary Jo Lamberti, PhD

Informa Decentralized Clinical Trials

Boston, MA | April 19

 

Quantifying the Value Proposition of DCT Deployment

Ken Getz, MBA

Informa Decentralized Clinical Trials

Boston, MA | April 18 - 20 

 

State of the Drug Development Industry

Ken Getz, MBA

Chief Medical Officers Summit

Boston, MA | April 3 - 4

 

 

 


March 2023

Assessing Patient Engagement Capabilities and Their Impact

Ken Getz, MBA

DIA Europe

Basel, Switzerland | March 23

 

Examining Current Patient Engagement Activities and Investment Within Sponsor and CRO Companies

Ken Getz, MBA

DIA Europe

Basel, Switzerland | March 22

 

 


February 2023

The Impact of Decentralized and Hybrid Trials on Sponsor-CRO Collaborations

 Mary Jo Lamberti, PhD

SCOPE Summit

Orlando, FL | December 8

 

Panel Discussion- Navigating Global Crises: Pandemic War, Hyperinflation and Supply Chain

Ken Getz, MBA

SCOPE Summit

Orlando, FL | February 7

 

 


January 2023

Remote Teams in Clinical Research During the COVID-19 Pandemic

Maria Florez, MA and Mary Jo Lamberti, PhD

Clinical Research Webinar

Virtual | January 26-27

 

Clinical Operations and Clinical Outsourcing Roundtables

Ken Getz, MBA

Linking Leaders

New York, NY | January 17-18


December 2022

New Insights into Managing Investigative Sites to Optimize Patient Enrollment Diversity

Ken Getz, MBA

Evolution Summit

Orlando, FL | December 8

 

Clinical Research Professionals and the Shift to Remote Work During the COVID-19 Pandemic

Maria Florez, MA and Mary Jo Lamberti, PhD

Clinical Operations in Oncology, Virtual Conference

Virtual | December 1


November 2022

Measuring the Impact of the Pandemic on Drug Development Productivity and Performance

Ken Getz, MBA

Outsourcing Clinical Trials New England

Boston, MA | November 10

 

New Trends and Practices Impacting the Drug Development Landscape

Ken Getz, MBA

CT Europe

Live | November 7-9

 

Increasing Efficiency and Reducing Cycle-Times in Drug Development: Multi-Stakeholder Views on the Topic

Zachary Smith, MA

Clinical Trials Europe

Virtual | November 3

 

Where Has the Industry Been and Where Should it Be Going?

Joseph DiMasi, PhD

Speid & Associates Inc. and Brown University Medical School

Virtual | November 2-4

 

Impact of Running Clinical Trials During the Pandemic and Lessons Learnt

Ken Getz, MBA and Maria Florez, MA

Clinical Trials Europe

Virtual | November 2-4

 

Digital Transformation and Clinical Research Team Effectiveness

Maria Florez, MA

Clinical Trials Europe

Virtual | November 2-4

 

Optimizing Protocol Design to Improve Performance and Efficiency

Ken Getz, MBA

Clinical Trials Europe

Virtual | November 2

 


October 2022

Digitizing Clinical Trials

Maria Florez, MA

18th Clinical Trials Innovation Programme

Boston, MA | October 26-27

 

The Economics of Decentralized Clinical Trials: Assessing the Net Financial Benefit

Joseph DiMasi, PhD

Decentralized Clinical Trials Summit

Philadelphia, PA | October 26

 

Accommodating and Managing Agile Drug Development Execution

Ken Getz, MBA

Chief Medical Officers Summit

Virtual | October 14

 

Exploring the Impact of Decentralized Clinical Trials

Ken Getz, MBA

Prometrika

Live & Virtual | October 13

 

The Impact of Decentralized Trials on Sponsor-CRO Collaborations

Mary Jo Lamberti, PhD

Outsourcing in Clinical Trials New England

Boston, MA | October 12-13

 

Impact of COVID-19 on Clinical Operations

Ken Getz, MBA

Dutch Federation of Pharmaceutical Medicine

Virtual | October 7

 

Diversity and Representation Among the Clinical Research Workforce: A factor in patient engagement and recruitment?

Maria Florez, MA

Scope Europe

Barcelona | October 3-4

 

Characterizing the Innovation Adoption Cycle for Innovations Supporting Virtual Clinical Trials

Maria Florez, MA

Scope Europe

Barcelona | October 3-4

 


September 2022

 
How We Become Agile to Remain Viable in a Post-COVID World

Ken Getz, MBA

DPharm

Virtual | September 29

 

Innovation Adoption Cycles for Tools Supporting DCT Research

Maria Florez, MA

Precision in Clinical Trials Summit

Frankfurt | September 28

 

Racial and Ethnic Disparities in Access to Professional Opportunities in Drug Development

Emily Botto, BA

Clinical Trials Global

Virtual | September 28

 

Accelerating Innovation Adoptions Supporting Clinical Trial Execution

Ken Getz, MBA

CTTI Fall Steering Committee Meeting

Washington D.C. | September 20

 

CRO Landscape Trends - Sponsor Demand, Sector Growth, and the Impact of COVID-19

Emily Botto, BA

Contract Pharma

New Brunswick, NJ | September 20

 

Evolving the Biomedical Innovation System

Ken Getz, MBA

IQVIA Life Sciences Innovation Forum

Virtual | September 13

 

The Changing Environment for RBQM

Ken Getz, MBA

RBQM Live

Virtual | September 8